Latest Stories
3 Reasons to Avoid EXPO and 1 Stock to Buy Instead
Since September 2025, Exponent has been in a holding pattern, posting a small loss of 1% while floating around $70.25.
3 Reasons We’re Fans of DXP (DXPE)
DXP currently trades at $140.21 and has been a dream stock for shareholders. It’s returned 308% since March 2021, blowing past the S&P 500’s 72.4% gain. The company has also beaten the index over the past six months as its stock price is up 18.4% thanks to its solid quarterly results.
3 Reasons Investors Love Airbnb (ABNB)
Airbnb has followed the market’s trajectory closely, rising in tandem with the S&P 500 over the past six months. The stock has climbed by 7.7% to $132.49 per share while the index has gained 3.1%.
3 Reasons BHF is Risky and 1 Stock to Buy Instead
Over the past six months, Brighthouse Financial has been a great trade, beating the S&P 500 by 20.2%. Its stock price has climbed to $60.28, representing a healthy 23.3% increase. This run-up might have investors contemplating their next move.
3 Reasons to Sell FNB and 1 Stock to Buy Instead
F.N.B. Corporation currently trades at $16.26 per share and has shown little upside over the past six months, posting a small loss of 1.1%.
3 Reasons We’re Fans of Marsh & McLennan (MRSH)
Over the past six months, Marsh & McLennan’s shares (currently trading at $175.81) have posted a disappointing 13.6% loss, well below the S&P 500’s 3.1% gain. This may have investors wondering how to approach the situation.
Global Industrial (GIC): Buy, Sell, or Hold Post Q4 Earnings?
Over the past six months, Global Industrial’s shares (currently trading at $31.53) have posted a disappointing 17.8% loss, well below the S&P 500’s 3.1% gain. This may have investors wondering how to approach the situation.
SouthState (SSB): Buy, Sell, or Hold Post Q4 Earnings?
Over the past six months, SouthState’s shares (currently trading at $93.66) have posted a disappointing 8.4% loss, well below the S&P 500’s 3.1% gain. This may have investors wondering how to approach the situation.
Incyte (INCY): Buy, Sell, or Hold Post Q4 Earnings?
Over the past six months, Incyte has been a great trade, beating the S&P 500 by 8.1%. Its stock price has climbed to $95.88, representing a healthy 11.3% increase. This was partly due to its solid quarterly results, and the run-up might have investors contemplating their next move.
3 Reasons ADT is Risky and 1 Stock to Buy Instead
Shareholders of ADT would probably like to forget the past six months even happened. The stock dropped 24.4% and now trades at $6.69. This may have investors wondering how to approach the situation.